Aegerion Pharma Stock Price (NASDAQ:AEGR)

Add to My Stocks
$1.97 $0.1 (5.35%) AEGR stock closing price Nov 29, 2016 (Closing)
Prev Close* : $1.87
Market Cap:
Day Low: $1.86
52 Week Low: $1.23
Open: $1.89
Volume: 2168985
Day High: $2.34
52 Week High: $10.85

Latest Stock Market News

Latest Articles

Aegerion Pharma News - From Partners

AEGR Stockcharts

View AEGR PE ratio, PS ratio stocks charts and compare with peers.
AEGR Chart
Note: Compare Aegerion Pharma stock price history with the index and industry peers.

AEGR Industry Peers

Company Price Change (%)
Flex Pharma (FLKS)3.440.16 (4.44%)
Transition Therapeutics (TTHI)1.530 (0%)
Amgen (AMGN)185.760.88 (0.47%)
Esperion Therapeutics (ESPR)49.310.06 (0.12%)
Ionis Pharma (IONS)51.320.51 (0.98%)
Capstone Therapeutics Corp. (CAPS)0.060 (0%)
Gemphire Therap (GEMP)9.880.36 (3.52%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Celldex Therapeutics (CLDX)2.660.2 (8.13%)
MediciNova (MNOV)6.180.3 (5.1%)
Fate Therapeutics (FATE)4.120.18 (4.57%)
Alder BioPharma (ALDR)10.850.4 (3.83%)
Athersys (ATHX)2.550.08 (3.24%)
Vital Therapies (VTL)4.90.15 (3.16%)
Top gainers from Medical-Biomed-Genetics industry
* As of Sep 23, 2017
CompanyPriceChange (%)
Intercept Pharma (ICPT)61.5912.11 (16.43%)
Exelixis (EXEL)24.473.54 (12.64%)
Epizyme (EPZM)16.951.75 (9.36%)
Amicus Therapeutics (FOLD)14.611.17 (7.41%)
Chromadex (CDXC)40.3 (6.98%)
Arbutus Biopharma (ABUS)6.550.45 (6.43%)
AKARI THERAPTC (AKTX)8.180.56 (6.41%)
Top losers from Medical-Biomed-Genetics industry
* As of Sep 23, 2017

Aegerion Pharmaceuticals, Inc. Stock News - Partner Headlines

Stocks Reach 5-Year Lows   on Apr 11, 2016
Stocks Reach 5-year Lows   on Apr 04, 2016
Stocks Fall to 5-Year Lows   on Mar 28, 2016

Aegerion Pharma Financial Statements

income statement20152014201320122011
Net Sales or Revenues239.88M158.37M48.54M--
Net Income-73.33M-39.38M-63.35M-62.26M-39.46M
Total Operating Expense232.73M170.7M105.86M60.6M39.31M
View Aegerion Pharma income statement
balance sheet20152014201320122011
Total Assets434.19M417.45M142.33M85.08M75.56M
Total Liabilities318.65M257.16M29.3M24.68M18.36M
Shareholders Equity115.54M160.29M113.03M60.4M57.2M
View Aegerion Pharma balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) in Assets Liabilities20.93M-3.98M-5.57M5.73M2.27M
Net Cash from (used by) Operating Activities15.98M-2.05M-38.38M-42.55M-30.5M
Increase (Decrease) in Prop Plant And Equipment-1.87M-3.94M-0.71M-0.81M-0.63M
View Aegerion Pharma cash flow statement

Aegerion Pharma Stock Message Board

An investor needs to spend 1.97 to buy AEGR stock, as the closing Aegerion Pharma stock price is 1.97. The total market value as denoted by 58.2M for Aegerion Pharma, is the market value of the company's outstanding shares. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Aegerion Pharma stock analysis.

For recognizing and analyzing the real performance of Aegerion Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume number in Aegerion Pharma stock quote data shows the number of shares traded. For Ex: 2168985 Aegerion Pharma shares were traded as of last trading day, as seen from Aegerion Pharma stock chart. Aegerion Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.